Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy
NCT ID: NCT00725387
Last Updated: 2019-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
214 participants
OBSERVATIONAL
2007-08-31
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases
NCT00375830
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
NCT01541358
18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
NCT02079181
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
NCT02809690
Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma
NCT00188929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must understand and voluntarily sign an Informed Consent form after the contents have been fully explained to them
Exclusion Criteria
* Pregnant women
* Healthy volunteers
* Patients participating in other research studies
The subjects will not be paid to participate in this protocol. No costs will be charged to the subjects.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrei Iagaru M.D
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Aalborg Hospital
Aalborg, , Denmark
Apollo Hospital
Chennai, , India
Coimbra University Hospital
Coimbra, , Portugal
Pretoria Academic Hospital
Pretoria, , South Africa
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Iagaru A, Mittra E, Mosci C, Dick DW, Sathekge M, Prakash V, Iyer V, Lapa P, Isidoro J, de Lima JM, Gambhir SS. Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial. J Nucl Med. 2013 Feb;54(2):176-83. doi: 10.2967/jnumed.112.108803. Epub 2012 Dec 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
98043
Identifier Type: OTHER
Identifier Source: secondary_id
SU-07232008-1266
Identifier Type: OTHER
Identifier Source: secondary_id
VAR0024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.